HMC Capital Limited Overview
HMC Capital is an ASX-listed diversified alternative asset manager that originated as a property owner — the vehicle that bought and repurposed the former Masters Home Improvement portfolio — and evolved into a multi-platform manager across real estate, private credit, digital infrastructure and energy, with private equity now wound down. It manages roughly $18.6bn of AUM (FY26, excluding US Stratcap) and $16.9bn of fee-generating AUM for institutional, high-net-worth and retail investors. Its model is "seed, scale, syndicate": use the balance sheet to originate large, complex transactions, then transfer assets into listed REITs (HomeCo Daily Needs REIT, HealthCo Healthcare & Wellness REIT, DigiCo Infrastructure REIT) and unlisted funds that pay recurring fees, while HMC keeps material co-investments. After an extraordinary 2019–2024 growth phase and a share price collapse of more than 75% from its November 2024 peak, the group spent FY26 simplifying: exiting US digital operations, closing HMCCP, bringing KKR into its energy platform and adding institutional credit mandates.
Company's own description (paraphrased from FY26 Annual Report)
HMC Capital describes its principal activity as funds management through owning and managing real-asset funds exposed to high-conviction global megatrends. Its stated objective is to deliver above-average risk-adjusted returns to shareholders. It does this by investing in scalable real-asset strategies alongside third-party capital in HMC-managed funds, while maintaining an appropriate capital structure. In its boilerplate "About" text, the company says its point of difference is the ability to execute large, complex transactions, which it credits for rapid FUM growth (FY26 Results Announcement).
Independent characterisation
HMC is best understood as a hybrid between a fee-earning alternative asset manager and a listed principal investor:
-
Fee engine (asset-light). Base management fees from listed REITs (HDN, HCW, DGT), unlisted real estate funds (HARP, HUG, LML Fund, Unlisted Healthcare Fund), private credit funds and mandates (Payton-originated CRE lending), and Illuma Energy. Recurring funds management revenue was $165.5m in FY26, up 22% (FY26 Results Announcement).
-
Transaction and performance fees (episodic). Acquisition, development and capital-raising fees, plus performance fees. FY25 included a $24.7m HMCCP performance fee, $59.1m of DGT-related fees and $1.7m in Real Estate. FY26 included a $35m energy transaction fee tied to the KKR partnership.
-
Principal investments (balance-sheet heavy). About $1.4bn of balance-sheet investments, chiefly co-investment stakes in HDN (10.5%), HCW (22.7%), DGT (20.7%) and Illuma Energy (~$200m remaining), plus retained listed equities from the former HMCCP portfolio. These produce distributions, realised gains and — under fair-value and equity accounting — large swings in statutory profit.
Revenue model mix
| Revenue type | Description | FY26 indicator |
|---|---|---|
| Base management fees (recurring) | % of AUM or GAV in listed and unlisted vehicles | Recurring FM revenue $165.5m (FY26) |
| Transaction / acquisition / development fees | Charged on deployment, developments and capital events | $35m energy fee (FY26) |
| Performance fees | Hurdle-based, mainly HMCCP historically | Nil in FY26 vs $24.7m in FY25 |
| Investment income | Distributions, dividends, realised and unrealised gains on co-investments | Share of associate distributions $32.9m; dividend income $15.2m; fair value loss $(133.3)m |
| Corporate services fees | Services to managed platforms | $5m p.a. from Illuma Energy (Kalkine, 6 Feb 2026) |
There are no product sales, licensing or subscription revenues in the conventional sense. Using FY26 continuing revenue of $181.9m, the business is effectively ~100% services, of which about 90% is recurring management fees once the $35m one-off energy fee is excluded (derived).
Value chain position, customers and end-markets
Value chain: sponsor → originator/acquirer → developer → fund manager → asset manager. HMC sits at the top of the chain as sponsor and capital allocator, outsourcing most property operations to tenants and service providers.
Customer types (capital providers): ASX retail and institutional securityholders of the listed REITs; wholesale and high-net-worth investors (private credit funds, formerly HMCCP); global institutions (KKR in energy; TPG Credit and other global institutional mandates in private credit).
End-markets (asset users): convenience/daily-needs and large-format retail tenants (HDN); healthcare operators including hospital operators (HCW / UHF); data centre customers including hyperscale and enterprise users (DGT); electricity off-takers and the market operator via Capacity Investment Scheme contracts (Illuma); commercial real estate borrowers (Private Credit).
Strategy
Stated strategy (paraphrased themes from the FY26 Annual Report and Results)
-
Simplify, scale, strengthen. FY26 was framed as a year of execution: narrowing the business, scaling institutional partnerships and rebuilding balance sheet capacity.
-
Seed–scale–syndicate. Use the balance sheet to acquire or originate undervalued real assets, then syndicate them to third-party capital and retain co-investments (FY26 Presentation).
-
Focus on high-ROE Australian platforms. The priorities are Real Estate, Private Credit, Digital Infrastructure (via DGT, refocused on Australia) and Energy (via Illuma, now capital-light).
-
Institutionalisation. The aim is to attract long-dated global institutional capital, as with KKR and TPG Credit.
-
Recurring earnings and cash conversion. Underlying EPS is the new key metric, with 100% cash conversion targeted in FY27.
Initiatives announced in the last 24 months
| Date | Initiative | Detail / target |
|---|---|---|
| Nov 2024 | $50bn+ AUM and 20% ROE ambition (3–5 years) | Reiterated through 2025; the DGT-specific aspiration of $50bn was scaled back by Sep 2025 (Kalkine) |
| 2H FY25 | Launch of HARP and HUG | Targeting up to $2bn of AUM |
| Aug 2025 | Private Credit Core Fund raising | Wholesale channel expansion |
| Aug 2025 | FY26 targets | ≥40c OE; Real Estate FM EBITDA +15%; Private Credit FM EBITDA +20%; nil permanent core debt |
| Feb 2026 | KKR energy partnership | Up to $603m; deconsolidation; $35m fee |
| May 2026 | Group restructure | HMCCP closure; StratCap wind-down; support function integration; DGT US asset sales |
| Jun 2026 | Private credit mandates | $1.35bn, including the TPG Credit partnership (>$1bn of institutional capital) |
| FY26 | Cost programme | Savings from simplification support FY27 guidance (quantum n/d) |
| FY26–FY27 | Sustainability strategy refresh | To align with the Digital and Illuma platforms; AASB S2 climate reporting mandatory from FY27 |
Medium-term guidance
| Metric | FY27 guidance |
|---|---|
| Underlying EPS, pre-tax (AUD cents) | ≥35.0 (+16% vs 30.2c) |
| DPS (AUD cents) | 15.0 (+25%) |
| Recurring FM revenue growth (%) | >30 |
| Co-investment distribution growth (%) | ~35 |
| Cash conversion of underlying earnings (%) | 100 |
Guidance excludes upside from recycling capital out of the $1.4bn of balance-sheet investments and any realised investment income (FY26 Results Announcement).
Products & Services
Real Estate
| Vehicle | Type | Description | Target investor | Launch | Fee model / HMC stake |
|---|---|---|---|---|---|
| HomeCo Daily Needs REIT (ASX: HDN) | Listed A-REIT | Convenience, neighbourhood and large-format retail centres anchored by daily-needs tenants | Retail and institutional | Nov 2020 IPO | External management fees; HMC 10.5% (FY26 4E) |
| HealthCo Healthcare & Wellness REIT (ASX: HCW) | Listed A-REIT | Hospitals, aged care, childcare, life sciences and health precincts | Retail and institutional | 2,021 | External management fees; HMC 22.7% (FY26 4E) |
| Unlisted Healthcare Fund (UHF) | Unlisted wholesale | Healthcare real estate including Healthscope-leased hospitals | Institutional/wholesale | ~FY23–FY24 | Mgmt fees; 15% IRR since inception at 1H FY24 |
| Last Mile Logistics (LML) Fund I | Unlisted | Urban infill logistics; ~$1.0bn fully deployed; ~$140m near-term development pipeline | Institutional/wholesale | ~FY23 | Mgmt fees; 23% IRR since inception at 1H FY24 |
| HMC Australia Retail Partnership (HARP) | Unlisted institutional | Retail/daily-needs strategy with institutional partner(s) | Institutional | 2H FY25 | Mgmt fees |
| HMC Unlisted Grocery Fund (HUG) | Unlisted | Grocery-anchored assets; ~$1.2bn development program | Institutional/wholesale | 2H FY25 | Mgmt and development fees |
| Real estate development pipeline | Balance sheet / funds | ~$1.4bn pipeline, including HDN development optionality | — | Ongoing | Development fees |
HARP and HUG were initially targeting up to $2bn of combined AUM (FY25 Results Presentation).
Private Credit
| Offering | Description | Target investor | Launch | Notes |
|---|---|---|---|---|
| HMC Private Credit (ex-Payton Capital) | Senior secured commercial real estate lending | Wholesale and HNW | Acquired 2024 | ~$1.6bn AUM at acquisition |
| HMC Private Credit Core Fund | Open-ended wholesale fund | Wholesale | Capital raising launched Aug 2025 | $100m Core Fund raise noted in FY25 |
| Institutional mandates (incl. TPG Credit partnership) | Separately managed CRE lending mandates | Global institutions | June 2026 | ~$1.35bn funding; ~$375m of seed loans at financial close; balance in FY27 |
FY26 platform AUM was ~$2.3bn, with a pipeline of more than $4bn under evaluation and more than $1bn of committed capital available (FY26 Remuneration Report).
Digital Infrastructure
| Asset / vehicle | Description | Status |
|---|---|---|
| DigiCo Infrastructure REIT (ASX: DGT) | Data centre owner/developer; HMC 20.7% stake | Listed Dec 2024; strategy refocused on Australia in FY26 |
| SYD1 (Sydney, ex-Global Switch) | Hyperscale/enterprise facility <1km from the Sydney CBD; first 20MW expansion delivered; LOIs signed for the remaining 52MW; holds "Strategic Certification" under the Hosting Certification Framework | Expansion fully funded across FY27–FY28 |
| iseek | Australian co-location platform (seed asset) | Retained |
| CHI1 (Chicago, Elk Grove Village) | US enterprise/hyperscale data centre | Sale agreed at US$750m (~5% premium to Nov 2024 cost; 5.8% passing yield); ~A$360m net proceeds; close expected 1Q FY27 |
| LAX1 / LAX2 (Los Angeles) | Development land; book value ~US$71m | Being monetised; LAX1 application withdrawn |
| Dallas-Fort Worth, Kansas City | US operating assets | Retained as core |
| StratCap (USA) | US digital infrastructure funds manager acquired Sep 2024 | Discontinued operation; wind-up underway |
Sources: DGT releases (6 May 2026), Reuters/DealStreetAsia, Mingtiandi, CoStar, FY26 Results.
Energy — Illuma Energy
| Project / component | Description | Status |
|---|---|---|
| Illuma Energy platform | Renewable generation and storage developer/owner; HMC 80% economic interest, equity accounted, joint control with KKR | KKR financial close 30 Jun 2026 |
| Kentbruck Wind Farm (VIC) | Up to ~600MW wind; approved; Capacity Investment Scheme commitments | Off-take negotiations reported as advanced (RenewEconomy, Feb 2026) |
| Moorabool BESS (VIC) | Up to ~600MW battery; Capacity Investment Scheme Agreement awarded | First BESS FID; KKR to fund up to $248m |
| Neoen Victorian portfolio | Acquired 1 Aug 2025 for ~$950m | Integrated |
| STOR-Energy | Battery developer; remaining equity acquired | Integrated |
| Pipeline | ~5GW (FY26), described earlier as 5.7GW across 19 projects | ~2.3GW targeted for FID within 12–18 months of Feb 2026 |
HMC's remaining investment is approximately $200m. HMC has stated an IRR target above 20% and a ~4x money multiple over five years, and receives $5m p.a. for corporate services (FY26 Results; RenewEconomy; Kalkine).
Private Equity (discontinued)
| Vehicle | Description | Outcome |
|---|---|---|
| HMC Capital Partners Fund I (HMCCP) | Concentrated stakes in ASX/NZX-listed companies (e.g., Sigma Healthcare, Ingenia Communities, Baby Bunting, Lendlease) | Returned 56.2% net in CY24 and 43.6% net in FY25; wound up June 2026; inception investors earned a ~17.5% IRR (Stocks Down Under) |
| HMC Capital Partners Retail Fund I | Retail feeder | Closure announced 1 Apr 2025; proceeds distributed July 2025; wind-up completed 23 Apr 2026 |
| HMCCP Fund II | Proposed closed-end fund (Healthscope recapitalisation flagged as an opportunity) | Not launched in practice (no subsequent capital-raising disclosure identified) |
Financial Narrative
Important framing. HMC is an asset manager with a large principal investment book. Gross profit, EBITDA and gross margin are not reported in their conventional form. Statutory profit is dominated by fair value movements and equity-accounted results. Management's primary metrics have been Operating Earnings (OE) through FY26 and Underlying Earnings from FY27.
Income statement (chartable)
Sources and notes:
-
FY26 Appendix 4E and Financial Report; FY26 Remuneration Report Table 10 (OE cps, NPAT, DPS for FY21–FY26); FY24 Results and Quartr summary (FY24 revenue $189.5m, post-tax OE $115.0m); Australian Property Journal (FY24 FV gains $121.4m).
-
FY23 pre-tax OE is derived from the reported +57% growth to $129m.
-
FY21: OE pre-tax 13.1c, NPAT $(85.9)m.
-
FY26 underlying EPS (pre-tax, excluding Stratcap) was 30.2c, and OE excluding discontinued operations was 43.7c.
Margins (derived)
Gross margin and EBITDA margin are not meaningful or not disclosed for this business model. OE-based margins exceed "normal" levels because OE includes investment income that sits outside revenue.
Growth
Derived from Table 10 OE cps and reported AUM. FY26 AUM growth is calculated on a like-for-like basis against the restated FY25 base excluding Stratcap: $18.2bn → $18.6bn = +2.2%. Against the originally reported $18.7bn, the change is -0.5%. Revenue CAGR FY24–FY26 (incl. discontinued) is -0.3% p.a. (derived: 189.5 → 188.2). Operating EPS CAGR FY21–FY26 is 25.3% p.a. (13.1c → 40.4c, derived).
Balance sheet (chartable)
Notes:
-
FY24 cash and equity are from opening balances in the FY25/FY26 statements. FY24 attributable equity is derived (1,506.8 less NCI of 283.9).
-
Consolidated net debt is derived (borrowings less cash).
-
Corporate net debt is as stated by the company and excludes $105m of non-recourse fund facilities. FY25 corporate balance sheet was net cash, entered as 0.
-
Working capital is derived (current assets less current liabilities).
-
Group debt facility is $715m (upsized from $675m), with $176.6m drawn plus $42.9m of bank guarantees. Gearing is 10.7% and the weighted average cost of debt is 6.5%. The facility matures 26 November 2027.
Cash flow (chartable)
FCF is derived as OCF less PP&E capex. Commentary: OE-to-cash conversion has been weak because management fees were partly paid in scrip or deferred, and because investment income is largely non-cash. Management guides to 100% conversion of FY27 underlying earnings to cash as these non-cash fee arrangements end (FY26 Results Announcement).
Ratios (derived from statutory accounts)
n/m = not meaningful for an asset manager without inventory or a reported EBITDA. Management targets a 20% ROE through the cycle.
Trend commentary
FY22–FY24 (platform building). Operating EPS went from 30.3c (FY22) to 26.4c (FY23) and then 37.0c (FY24). The FY23 dip reflected weaker investment income in a rising-rate environment. FY24 benefited from management fee growth (+14% to $79.7m), an HMCCP revaluation and a $15.6m performance fee. AUM rose 30% to $12.7bn, helped by Payton and StratCap being counted in AUM.
FY25 (peak). Pre-tax OE rose 74% to $224.6m, driven by the DGT IPO (large transaction fees of $59.1m), the HMCCP performance fee ($24.7m) and strong principal investment gains, including Sigma Healthcare during its merger with Chemist Warehouse. Statutory NPAT more than doubled to $265.2m, including $117.9m attributable to NCI. A $300m equity raising and SPP lifted contributed equity by $335.5m.
FY26 (reset and simplification). OE fell 26% to $166.8m (40.4c) as FY25's one-off fees rolled off. Recurring FM revenue grew 22%, which supports management's claim that earnings quality improved. Statutory results swung to a $111.6m loss. The drivers were fair value losses of $133.3m, an associate loss of $51.1m (including $57.4m from Illuma), a $32m impairment and a $68.0m loss from discontinued Stratcap. Cash fell to $19.4m and drawn debt rose to $176.6m, so the corporate balance sheet moved from net cash to modest net debt of $158.1m. NTA per share fell 21% to $2.86.
Inflection to watch. FY27 guidance of ≥35c underlying EPS (+16%) relies on >30% recurring FM revenue growth, ~35% higher co-investment distributions and cost savings. FY27 is therefore the first year in which the "simplified HMC" can be tested against a cleaner earnings metric.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Per-Share Data
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Revenue incl. discontinued ops (AUD Mn) | — | — | 189.5 | 234.2 | 188.2 |
Revenue continuing ops, re-presented (AUD Mn) | — | — | — | 227.8 | 181.9 |
Total revenue and other income ex-FV, continuing (AUD Mn) | — | — | — | 258.2 | 232.4 |
Change in FV of assets/liabilities (AUD Mn) | — | — | 121.4 | 269.7 | -133.3 |
Pre-tax operating earnings (AUD Mn) | — | 82.4 | 129.3 | 224.6 | 166.8 |
Post-tax operating earnings (AUD Mn) | — | — | 115.0 | 211.9 | 199.4 |
Statutory profit before tax, continuing (AUD Mn) | — | — | — | 297.0 | -76.2 |
Statutory NPAT incl. NCI (AUD Mn) | 107.3 | 83.3 | 114.4 | 265.2 | -111.6 |
NPAT attributable to owners (AUD Mn) | — | — | — | 147.3 | -49.1 |
Operating EPS pre-tax (AUD cents) | 30.3 | 26.4 | 37.0 | 56.0 | 40.4 |
Basic EPS statutory (AUD cents) | — | — | — | 36.76 | -11.90 |
Diluted EPS statutory (AUD cents) | — | — | — | 36.51 | -11.90 |
Dividend per share (AUD cents) | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 |
Weighted average shares (M) | — | — | — | 400.8 | 412.6 |
Margin Analysis (%)
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
Pre-tax OE / revenue incl. discontinued (%) | 68.2 | 95.9 | 88.6 |
Statutory NPAT incl. NCI / revenue (%) | 60.4 | 113.2 | -59.3 |
Operating margin as reported by company (%) | 68 | — | — |
Margin Analysis (%) (FY22–FY26)
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Operating EPS growth YoY (%) | 131.3 | -12.9 | 40.2 | 51.4 | -27.9 |
AUM growth YoY (%) | — | — | 30 | 47 | -0.5 |
Balance Sheet and Per-Share Data
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
Total assets (AUD Mn) | — | 2,180.6 | 1,985.1 |
Cash and equivalents (AUD Mn) | 186.6 | 120.9 | 19.4 |
Borrowings current (AUD Mn) | — | 129.3 | 0 |
Borrowings non-current (AUD Mn) | — | 0 | 280.6 |
Consolidated net debt (AUD Mn) | — | 8.4 | 261.2 |
Corporate net debt per company (AUD Mn) | — | 0 | 158.1 |
Total equity incl. NCI (AUD Mn) | 1,506.8 | 1,881.4 | 1,541.8 |
Equity attributable to owners (AUD Mn) | 1,222.9 | 1,658.9 | 1,541.8 |
Intangible assets incl. goodwill (AUD Mn) | — | 393.3 | 360.8 |
Equity-accounted investments (AUD Mn) | — | 992.7 | 1,213.9 |
Working capital (AUD Mn) | — | 533.9 | 161.3 |
NTA per share (AUD) | — | 3.61 | 2.86 |
NTA + undrawn debt (AUD Bn) | 1.4 | 2.0 | 1.9 |
Cash Flow
| Metric | FY25 | FY26 |
|---|---|---|
Operating cash flow (AUD Mn) | 31.0 | -22.6 |
Capex — PP&E (AUD Mn) | 8.6 | 7.1 |
Free cash flow (AUD Mn) | 22.4 | -29.7 |
Dividends paid to HMC shareholders (AUD Mn) | 47.4 | 49.6 |
Share buybacks (AUD Mn) | 0 | 0 |
Treasury share purchases (AUD Mn) | 7.5 | 2.8 |
Proceeds from share issues (AUD Mn) | 299.5 | 0 |
Distributions received from investments (AUD Mn) | 45.4 | 54.1 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY25 | FY26 |
|---|---|---|
ROE — attributable NPAT / avg attributable equity (%) | 10.2 | -3.1 |
ROE — pre-tax OE / avg attributable equity (%) | 15.6 | 10.4 |
ROA — NPAT incl. NCI / avg total assets (%) | — | -5.4 |
Current ratio (x) | 3.42 | 2.56 |
Debt / equity (%) | 6.9 | 18.2 |
Net debt / EBITDA | n/m | n/m |
Interest coverage — (pre-tax OE + finance costs) / finance costs (x) | 11.0 | 6.5 |
Asset turnover — revenue / avg assets (x) | — | 0.09 |
Cash conversion cycle | n/m | n/m |
Revenue by Region
| Region | FY24 | FY25 | FY26 |
|---|---|---|---|
Loss from discontinued operations, USA (AUD Mn) | 0 | -19.1 | -68.0 |
Foreign currency translation OCI (AUD Mn) | — | 0.4 | -13.2 |
Share Price and Margin Analysis (%)
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Share price at 30 June (AUD) | 4.51 | 5.06 | 7.21 | 5.10 | 2.97 |
Total shareholder return (%) | -14.3 | 12.8 | 45.4 | -24.9 | -34.0 |
Dividend per share (AUD cents) | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 |
Share Price & Returns
| Period | Return / data point |
|---|---|
All-time high | $13.16 (Nov 2024) |
CY2025 price change | -59.4% ($9.75 → $3.96) |
FY26 price change | -41.5% ($5.08 → $2.97) |
1-year (to Jun 2026) | -41.7% (5.10 → 2.97, price only, derived) |
3-year TSR (FY24–FY26) | -31% (FY26 Remuneration Report, LTI test) |
5-year price (Jun 2021 → Jun 2026) | -45.4% price only (5.44 → 2.97, derived; excludes the HDN in-specie distribution and dividends) |
2026 YTD range (to Aug) | Low $2.16, high $4.62 |
Last verified close | $3.15 (5 Aug 2026); +11% on 26 Aug 2026 results day |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
P / FY26 op EPS pre-tax (x) | 7.8 | 40.4c |
P / FY26 underlying EPS pre-tax (x) | 10.4 | 30.2c |
P / FY27 guided underlying EPS (x) | 9.0 | ≥35c |
Statutory P/E | n/m | Loss-making |
P / book (x) | 0.84 | Book value $3.74 per share |
P / NTA (x) | 1.10 | $2.86 |
EV / Sales (x) | 7.7 | EV ≈ $1.30bn market cap + $158.1m corporate net debt = ~$1.46bn; revenue $188.2m |
EV / EBITDA | n/m | EBITDA not reported |
FY26 dividend yield (%) | 3.8 | 12c |
FY27 guided dividend yield (%) | 4.8 | 15c |
Analyst Ratings & Targets
| Broker / source | Rating | Target (AUD) | Date |
|---|---|---|---|
Bell Potter | Buy | 8.15 | Late 2025 (Kalkine) |
Bell Potter | Positive on FY26 result; expects further gains | — | Aug 2026 (Motley Fool) |
Most recent rating per TipRanks | Buy | 3.60 | Mid-2026 |
UBS | Valuation reference 13.5x FY26e | — | Apr 2025 |
Market Matters | Holder (4% target weight) | — | Mid-2026 |
Debt Facilities
| Facility | Limit (AUD Mn) | Drawn incl. guarantees (AUD Mn) | Maturity |
|---|---|---|---|
Secured syndicated facility (incl. $50m bank guarantee facility) | 715.0 | 219.5 | 26 Nov 2027 |
Non-recourse facilities in consolidated private credit funds | 105.0 | — | — |
Analyst Conclusions
Management guidance (FY27)
Underlying EPS (pre-tax) of at least 35c, up 16%, and DPS of 15c, up 25%. The drivers are >30% recurring FM revenue growth (led by Digital and Private Credit), ~35% higher co-investment distributions from DGT, HCW and HDN, and cost efficiencies. Guidance excludes capital-recycling upside and realised investment income. Management expects 100% cash conversion.
Consensus growth
The ≥16% underlying EPS growth guidance is the most reliable anchor.
Bull case
-
Earnings quality inflection. Recurring FM revenue grew 22% in FY26 and is guided to grow >30% in FY27. With non-cash fee arrangements ending, cash earnings could finally track reported earnings.
-
Hidden asset value. The stock trades at ~0.84x book. Illuma retains a ~5GW pipeline with KKR funding the first BESS, and DGT's CHI1 sale at a premium to cost supports the credibility of carrying values.
-
Institutional platform. The KKR and TPG Credit mandates show global capital is willing to partner with HMC. Private credit could reach ~$3.3bn of AUM, with a pipeline above $4bn.
Bear case
-
Statutory reality. HMC lost $111.6m in FY26, NTA per share fell 21%, and operating cash flow was negative.
-
Dependence on stressed listed vehicles. Fee and distribution growth assumes that HCW resolves Healthscope and that DGT executes SYD1. Both vehicles have been significant underperformers.
-
Credibility deficit. Successive resets — the $50bn target, HMCCP structural changes then closure, the StratCap purchase then exit — mean execution must be demonstrated, not promised. The facility refinancing in late 2027 adds a timetable.
Catalysts and monitorables (next 12 months)
| Catalyst | Expected timing |
|---|---|
| AGM and trading update | ~Nov 2026 |
| CHI1 sale completion; LAX monetisation | 1Q–2Q FY27 |
| Binding SYD1 52MW leases (conversion from LOIs) | FY27 |
| Moorabool BESS FID; Kentbruck offtake | FY27 |
| Healthscope hospital re-leasing resolution | FY27 |
| Deployment of the private credit mandates (~$1bn post-seed) | FY27 |
| 1H FY27 result: tracking vs ≥35c underlying EPS | ~Feb 2027 |
| Balance-sheet recycling ($1.4bn) and any capital management | FY27 |
| Debt facility refinancing ahead of Nov 2027 maturity | 2H FY27 |
| First AASB S2 climate disclosures | FY27 annual report |
Analyst verdict
HMC Capital is in transition from an acquisitive, sponsor-led growth story to a simpler, recurring-fee asset manager. The share price has already priced in much of the damage from that transition. Between November 2024 and mid-2026 the stock fell from $13.16 to roughly $2–3. Over the same period the company recorded a $111.6m statutory loss, cut operating EPS from 56c to 40.4c, wrote down NTA per share to $2.86, and reversed three strategic bets: US digital infrastructure, the HMCCP fund structure and an unrestrained energy balance sheet.
Underneath the noise, the fee base looks sturdier than the headline numbers suggest. Fee-generating AUM grew 15% to $16.9bn and recurring FM revenue rose 22%. The company also brought in two credible global partners in KKR and TPG Credit. On management's FY27 guidance, the stock trades at about 9x underlying pre-tax earnings, roughly 0.84x book, with a forward yield near 5%. That is a modest multiple for an alternatives manager with founder alignment of about 10%.
The investment case depends on HMC delivering on its new, lower bar. The specific tests are converting SYD1's LOIs into binding leases, resolving the Healthscope hospitals, deploying the private credit mandates, and showing that cash earnings now match reported underlying earnings. Investors also need to watch related-party governance across the listed REITs and the refinancing due in November 2027.
On balance, HMC offers asymmetric but execution-dependent upside. Investors who are comfortable with key-person concentration and statutory volatility may find the discount to book and the FY27 growth guidance attractive. More cautious investors should probably wait for the 1H FY27 result to confirm the underlying earnings run-rate and cash conversion before concluding that the reset is complete.
Refresh the market price and analyst data before any investment use. This document is not investment advice.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Background (paraphrased) |
|---|---|---|---|
David Di Pilla | Managing Director & Group CEO; founder | Since 2016 | 20-year investment banking career, including 15+ years as Managing Director at UBS Investment Bank and earlier Vice President at JP Morgan; director of HDN, HCW and DGT; founder of Aurrum aged care |
Will McMicking | Group CFO | Founding-era executive | Leads capital, finance, tax and IT; led FY26 debt extension and upsize |
Victoria Hardie | Group COO (presented FY26 results); formerly Head of Private Equity | — | Led HMCCP and its wind-up |
Andrew Selim | Group General Counsel & Company Secretary | Joined 2017 | Formerly Senior Legal Counsel and Company Secretary at GPT Group; Senior Associate at Allens Linklaters |
Chris Maher | Managing Director, Head of Digital Infrastructure; DGT interim CEO | DGT CEO since mid-2025 | Stepped down from the DGT board in Oct 2025 |
Angela Karl | Managing Director, Head of Energy Transition (as of 1H FY25) | — | Current role post-Illuma n/d |
Renee Jacob | Investor Relations | — | — |
Sandra Francis | HR lead | Since 2022 (MarketScreener) | — |
Directors' Remuneration
| Executive | Base salary | Cash bonus | Super | Share-based (equity) | Share-based (cash-settled) | Other | Total FY26 | Total FY25 |
|---|---|---|---|---|---|---|---|---|
David Di Pilla | 1,060,395 | 0 | 30,000 | 2,632,648 | 10,740 | 69,665 | 3,803,448 | 3,035,240 |
Will McMicking | 660,846 | 325,133 | 30,000 | 370,426 | 0 | -5,899 | 1,380,506 | 1,273,170 |
Board of Directors
| Director | Role | Independent | Committees | Background (paraphrased) | Shares held (30 Jun 2026) | FY26 total remuneration (AUD) |
|---|---|---|---|---|---|---|
Chris Saxon | Chair (since 1 Jan 2021) | Yes | Chair, Remuneration & Nomination | Former Baker McKenzie partner; Chair of Baker McKenzie Australia 2012–2017; M&A and energy lawyer | 345,724 | 251,218 |
David Di Pilla | MD & CEO | No | — (attends by invitation) | See above | 43,109,398 | See 9.2 |
Greg Hayes | NED | No | Audit & Risk | Former CFO and Executive Director of Brambles; former CEO of Tenix; former director of Ingenia and HDN | 11,216,711 | 110,533 |
Kelly O'Dwyer | NED | Yes | Chair, Sustainability; Audit & Risk; Rem & Nom | Former federal Cabinet Minister; NED of EQT, HCW, DGT, Barrenjoey and the National Reconstruction Fund Corporation; joined the Magellan board 1 Jul 2026 | 133,113 | 149,757 |
Susan Roberts | NED | Yes | Chair, Audit & Risk; Sustainability | Former CEO of Lazard Asset Management Pacific; actuary | 88,314 | 140,679 |
Dr Chris Roberts AO | NED (since 27 Nov 2024) | Yes | Audit & Risk; Rem & Nom | Former Cochlear CEO (2004–2015); NED of Sigma Healthcare, Clarity Pharmaceuticals and HCW | 313,226 | 123,961 |
Fiona Pak-Poy | NED (since 27 Nov 2024) | Yes | Sustainability | Chair of Tyro; former NED of WiseTech; HBS MBA | 12,122 | 113,623 |
Board & Management Changes
| Date | Change |
|---|---|
27 Nov 2024 | Zac Fried and Brendon Gale retire; Chris Roberts AO and Fiona Pak-Poy join |
Nov 2024 | Julia Gillard appointed Chair of the energy transition platform |
Mid-2025 | DGT: Damon Reid moves from CEO to COO; Chris Maher becomes CEO |
10 Oct 2025 | Chris Maher leaves the DGT board while remaining CEO; Michael Juniper joins the DGT board |
FY26 | No changes to the HMC Board or committees (FY26 Remuneration Report) |
By Aug 2026 | Victoria Hardie presents as Group COO |
Major Shareholders
| Holder | Shares | % of 412.6M (derived) | Source |
|---|---|---|---|
David Di Pilla (and related parties) | 43,109,398 | 10.4 | FY26 Directors' Report |
Greg Hayes (and related parties) | 11,216,711 | 2.7 | FY26 Directors' Report |
Will McMicking | 2,905,743 | 0.7 | FY26 Remuneration Report |
All other directors combined | 892,499 | 0.2 | FY26 Remuneration Report |
Competitive Landscape
Competitors by Segment
| Vertical | Named competitors | Relative positioning of HMC |
|---|---|---|
Real estate funds management | Charter Hall Group, Dexus, Goodman Group, GPT Group (funds management), Centuria Capital, Vicinity Centres, Region Group (convenience retail), Lendlease Investment Management | Mid-sized; niche leadership in large-format and daily-needs retail via HDN; healthcare via HCW |
Private credit (CRE) | Qualitas, Metrics Credit Partners, La Trobe Financial, MA Financial, Pallas Capital, Merricks Capital | Smaller than leaders; differentiated by real estate origination heritage |
Digital infrastructure | NEXTDC, AirTrunk (Blackstone), CDC Data Centres, Macquarie Data Centres (Macquarie Technology), Equinix and Global Switch internationally | Small (SYD1-centric) but in a scarce CBD location |
Energy transition | Squadron Energy, Tilt Renewables, Edify Energy, Akaysha Energy (BlackRock), Neoen (other states), ACEN Australia | Development-stage pipeline; KKR backing adds credibility |
Diversified alternatives (listed peers) | Macquarie Asset Management, MA Financial Group, Charter Hall, Pinnacle Investment Management, GQG (listed equities) | HMC is the most "deal-sponsor"-style of the ASX alternatives managers |
Peer Comparison FY2026
| Metric | HMC Capital FY26 | Charter Hall | Qualitas | MA Financial |
|---|---|---|---|---|
AUM / FUM (AUD Bn) | 18.6 | — | — | — |
Revenue (AUD Mn) | 188.2 | — | — | — |
Earnings growth (%) | -27.9 (op EPS) | — | — | — |
Margin (%) | 88.6 (pre-tax OE / revenue) | — | — | — |
R&D intensity (%) | 0 | 0 | 0 | 0 |
Recent Developments
--



